» Articles » PMID: 20496170

Psychosocial Variables Associated with Colorectal Cancer Screening in South Australia

Overview
Journal Int J Behav Med
Publisher Informa Healthcare
Date 2010 May 25
PMID 20496170
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Population screening reduces mortality from colorectal cancer, yet factors associated with uptake of screening are incompletely understood.

Purpose: The purpose of the study was to determine demographic and psychosocial factors associated with participation in faecal occult blood test (FOBT)-based colorectal cancer (CRC) screening in an average risk community programme in Adelaide, South Australia.

Method: A questionnaire consistent with the Preventive Health Model was used to determine demographic and psychosocial differences between previous FOBT-based screening participants (n = 413, response rate 93.2%) and non-participants (n = 481, response rate 47.9%). Results were analysed by univariate and multivariate generalised linear modelling, and factors associated with participation were identified.

Results: Factor analysis of psychosocial items revealed an optimal three-factor solution (knowledge, faecal aversion, belief in the value of screening). Following multivariate analyses, two psychosocial and two demographic factors remained as predictors of FOBT screening behaviour: (1) items related to faecal aversion (Aversion), relative risk (RR) = 0.61, CI = 0.55-0.69, (2) perceptions about the value of screening (Value), RR = 1.45, CI = 1.13-1.85, (3) age band 65-69 (Age, five age bands, relative to age 50-54), RR = 1.43, CI = 1.16-1.76 and FOBT type (Test; three tests, Hemoccult, FlexSure, InSure randomly assigned, relative to Hemoccult: FlexSure: RR = 1.41, CI = 1.17-1.71, InSure: RR = 1.76, CI = 1.47-2.11.

Conclusions: The psychosocial factors associated with non-participation in FOBT-based CRC screening are amenable to interventions designed to improve participation. The small relative risks values associated with each predictor, however, raise the possibility that additional factors are likely to influence screening participation.

Citing Articles

Faecal immunochemical test for suspected colorectal cancer symptoms: patient survey of usability and acceptability.

Georgiou Delisle T, DSouza N, Davies B, Benton S, Chen M, Ward H BJGP Open. 2021; 6(1).

PMID: 34645655 PMC: 8958743. DOI: 10.3399/BJGPO.2021.0102.


The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens.

Osborne J, Flight I, Wilson C, Chen G, Ratcliffe J, Young G Patient Prefer Adherence. 2018; 12:1825-1836.

PMID: 30271126 PMC: 6154741. DOI: 10.2147/PPA.S172143.


Predictors of colorectal cancer screening intention among Iranian adults: an application of the preventive health model.

Besharati F, Karimi-Shahanjarini A, Hazavehie S, Bashirian S, Faradmal J J Prev Med Hyg. 2018; 59(2):E159-E166.

PMID: 30083624 PMC: 6069407.


Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study.

Hategekimana C, Karamouzian M Int J Health Policy Manag. 2016; 5(6):365-71.

PMID: 27285514 PMC: 4885727. DOI: 10.15171/ijhpm.2016.14.


A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.

Symonds E, Pedersen S, Baker R, Murray D, Gaur S, Cole S Clin Transl Gastroenterol. 2016; 7:e137.

PMID: 26765125 PMC: 4737873. DOI: 10.1038/ctg.2015.67.


References
1.
Subramanian S, Klosterman M, Amonkar M, Hunt T . Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004; 38(5):536-50. DOI: 10.1016/j.ypmed.2003.12.011. View

2.
Myers R, Ross E, Jepson C, Wolf T, Balshem A, Millner L . Modeling adherence to colorectal cancer screening. Prev Med. 1994; 23(2):142-51. DOI: 10.1006/pmed.1994.1020. View

3.
Weller D, Owen N, Hiller J, Willson K, Wilson D . Colorectal cancer and its prevention: prevalence of beliefs, attitudes, intentions and behaviour. Aust J Public Health. 1995; 19(1):19-23. DOI: 10.1111/j.1753-6405.1995.tb00291.x. View

4.
Robinson M, Pye G, Thomas W, Hardcastle J, Mangham C . Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance. Eur J Surg Oncol. 1994; 20(5):545-8. View

5.
Cole S, Young G, Esterman A, Cadd B, Morcom J . A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen. 2003; 10(3):117-22. DOI: 10.1177/096914130301000304. View